Literature DB >> 1704473

Oxygen-exacerbated bleomycin pulmonary toxicity.

T S Ingrassia1, J H Ryu, V F Trastek, E C Rosenow.   

Abstract

Bleomycin is an antineoplastic agent with potential for producing pulmonary toxicity, attributed in part to its free radical-promoting ability. Clinical and research experiences have suggested that the risk of bleomycin-induced pulmonary injury is increased with the administration of oxygen. We report a case in which the intraoperative administration of oxygen in the setting of previous bleomycin therapy contributed to postoperative ventilatory failure. Our patient recovered with corticosteroid therapy. Physician awareness of a potential interaction between oxygen and bleomycin may help reduce the morbidity and mortality related to bleomycin therapy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1704473     DOI: 10.1016/s0025-6196(12)60489-3

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  13 in total

1.  Supplemental oxygen therapy in bleomycin-induced pulmonary toxicity: REPLY.

Authors:  J Debnath
Journal:  Med J Armed Forces India       Date:  2011-07-21

2.  Oxidative Toxicology of Bleomycin: Role of the Extracellular Redox Environment.

Authors:  Ayed Allawzi; Hanan Elajaili; Elizabeth F Redente; Eva Nozik-Grayck
Journal:  Curr Opin Toxicol       Date:  2018-08-17

Review 3.  [Perioperative care of palliative patients by the anesthetist : medical, psychosocial and ethical challenges].

Authors:  C L Lassen; R Abel; L Eichler; Y A Zausig; B M Graf; C H R Wiese
Journal:  Anaesthesist       Date:  2013-08       Impact factor: 1.041

Review 4.  Pulmonary outcomes in survivors of childhood cancer: a systematic review.

Authors:  Tseng-Tien Huang; Melissa M Hudson; Dennis C Stokes; Matthew J Krasin; Sheri L Spunt; Kirsten K Ness
Journal:  Chest       Date:  2011-03-17       Impact factor: 9.410

5.  Postoperative acute respiratory distress syndrome in patients with previous exposure to bleomycin.

Authors:  Benjamin M Aakre; Richard I Efem; Gregory A Wilson; Daryl J Kor; John H Eisenach
Journal:  Mayo Clin Proc       Date:  2014-02       Impact factor: 7.616

Review 6.  Cysteine/cystine redox signaling in cardiovascular disease.

Authors:  Young-Mi Go; Dean P Jones
Journal:  Free Radic Biol Med       Date:  2010-12-03       Impact factor: 7.376

Review 7.  A Pound of Cure Requires An Ounce (or More) of Prevention: Survivorship and Complications of Therapy for Hematologic Malignancies.

Authors:  Marlise R Luskin; Rahul Banerjee; Sarah Del Percio; Alison W Loren
Journal:  Curr Hematol Malig Rep       Date:  2015-09       Impact factor: 3.952

8.  Pneumocystis pneumonia increases the susceptibility of mice to sublethal hyperoxia.

Authors:  James M Beck; Angela M Preston; Steven E Wilcoxen; Susan B Morris; Eric S White; Robert Paine
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

9.  Phase-directed therapy: TSG-6 targeted to early inflammation improves bleomycin-injured lungs.

Authors:  Andrea M Foskett; Nikolay Bazhanov; Xinyu Ti; April Tiblow; Thomas J Bartosh; Darwin J Prockop
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-11-15       Impact factor: 5.464

10.  A case of life-threatening post-operative diffuse alveolar hemorrhage in patient with recent chemotherapy -A case report-.

Authors:  Mi-Young Kwon; Yoon Kyung Lee; In-Cheol Choi; Eun Ho Lee; Nam-Yun Kim; Young-Jae Chang
Journal:  Korean J Anesthesiol       Date:  2011-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.